A patent review of adaptor associated kinase 1 (AAK1) inhibitors (2013-present)
{{output}}
Introduction: Adaptor-associated kinase 1 (AAK1) has been proposed as being a promising drug target for the treatment of a variety of neurological and psychiatric disorders, such as schizophrenia, cognitive deficits in schizophre... ...